HLA 항체와 관련상품
산타크루즈 바이오테크놀로지는 인간 백혈구 항원 연구를 위한 다양한 HLA 항체를 제공합니다. HLA 항체는 웨스턴 블롯팅(WB), 면역 침전(IP), 면역 형광(IF), 파라핀 내장 절편을 이용한 면역 조직 화학(IHCP), 유세포 분석(FCM), 효소 결합 면역 흡착 분석(ELISA) 등 다양한 연구 응용 분야와 호환됩니다. 인간 백혈구 항원은 펩타이드 조각을 T세포에 제시하여 면역 반응과 이식 적합성에 영향을 미치는 등 면역 체계에서 중요한 역할을 합니다. 인간 백혈구 항원을 이해하는 것은 면역학, 이식 생물학, 질병 연관성 연구 등의 연구에 필수적입니다. HLA 연구는 자가면역 질환과 병원체의 면역 회피 메커니즘에 대한 인사이트를 제공할 수 있습니다. 인간 백혈구 항원에 대한 연구는 장기 이식 성공률과 개인 맞춤형 의학 접근법에서 중요한 발견을 이끌어냈습니다. HLA 발현 패턴에 초점을 맞춘 연구는 조직 거부 반응과 호환성 매칭에 대한 지식을 향상시켰습니다. 산타크루즈 바이오테크놀로지의 HLA 항체는 전 세계 연구자들이 면역학 연구를 발전시키고 인간 건강의 획기적인 발견에 기여할 수 있도록 지원합니다.
HLA 항체
| Empty Table Header | 제품명 | 카탈로그# | ISOTYPE | EPITOPE | APPLICATIONS | Species | 引用 | RATING |
|---|---|---|---|---|---|---|---|---|
HLA class I 항체 (HP-1F7) | sc-69892 | mouse IgG1 κ | (h) | WB, IP, FCM | h | 7 | ||
HLA class I 항체 (YTH862.2) | sc-59206 | rat IgG2b | (h) | WB, IP, IF, FCM | h | 2 | ||
HLA class I 항체 (MEM-147) | sc-51672 | mouse IgG1 | (h) | WB (non-reducing), IP, FCM | h | new | ||
HLA-A 항체 (B-11) | sc-390473 | mouse IgM κ | 26-45 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 3 | ||
HLA-A 항체 (C-6) | sc-365485 | mouse IgG2b κ | 61-93 (h) | WB, IP, IF, IHC(P), ELISA | h | 9 | ||
HLA-A/B/C 항체 (LY5.1) | sc-52810 | mouse IgG1 κ | (h) | WB, IP, IF | h | 8 | ||
HLA-A/B/C 항체 (3F10) | sc-65288 | mouse IgG2a | (h) | IP, IF, FCM | h | 1 | ||
HLA-A2 항체 (BB7.2) | sc-32236 | mouse IgG2b κ | (h) | FCM | h | 12 | ||
HLA-B/C 항체 (A-3) | sc-166668 | mouse IgG1 κ | 126-145 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
HLA-B/C 항체 (A-4) | sc-166544 | mouse IgG2a κ | N-terminal (h) | WB, IP, IF, ELISA | h | new | ||
HLA-B7 항체 (BB7.1) | sc-53304 | mouse IgG1 κ | (h) | FCM | h | 2 | ||
HLA-B27 항체 (EP-4) | sc-59233 | mouse IgM | (h) | IF | h | new | ||
HLA-C 항체 (H-5) | sc-166134 | mouse IgG3 κ | 91-123 (h) | WB, IP, IF, IHC(P), ELISA | h | 1 | ||
HLA-C 항체 (C-8) | sc-166088 | mouse IgG1 κ | 91-123 (h) | WB, IP, IF, ELISA | h | 2 | ||
HLA-C 항체 (D-9) | sc-166057 | mouse IgG1 κ | 91-123 (h) | WB, IP, IF, ELISA | h | new | ||
HLA-D/DR/DQ 항체 (35) | sc-53305 | mouse IgG3 κ | (m) | IP, IF, FCM | h | 1 | ||
HLA-DM 항체 (MaP.DM1) | sc-32248 | mouse IgG1 κ | (h) | IF, FCM | h | 5 | ||
HLA-DMα 항체 (NB-B33) | sc-134356 | mouse IgG1 κ | 1-262 (h) | WB, IP, IF, IHC(P), ELISA | h | 1 | ||
HLA-DMβ 항체 (E-8) | sc-393548 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | h | 1 | ||
HLA-DMβ 항체 (DM.K8) | sc-69738 | mouse IgG1 κ | (h) | WB, IP, IF | h | new | ||
HLA-DOα 항체 (C-11) | sc-515446 | mouse IgG1 κ | 83-127 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
HLA-DOβ 항체 (DOB.L1) | sc-69739 | mouse IgG2b κ | (h) | WB, IP, IF, IHC(P) | h | 3 | ||
HLA-DP 항체 (G-9) | sc-390694 | mouse IgG2b κ | 69-102 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
HLA-DP 항체 (BRAFB6) | sc-33719 | mouse IgG2b κ | FL (h) | WB, IP, FCM | m, r, h | 6 | ||
HLA-DP 항체 (OX76) | sc-53077 | mouse IgG2a κ | (r) | FCM | m, r | new | ||
HLA-DP 항체 (DP 11.1) | sc-53308 | mouse IgG2a κ | (h) | WB, IP, IF, IHC(P), FCM | h | 4 | ||
HLA-DP β1 항체 (7-RE35) | sc-134357 | mouse IgG2a κ | 1-259 (h) | WB, IP, IF, IHC(P), ELISA | h | 1 | ||
HLA-DP/DR/DQ 항체 (PdV5.2) | sc-130013 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P), functional assay | h | 2 | ||
HLA-DP/DR/DQ 항체 (7.5.10.1) | sc-59238 | mouse IgG2a κ | (h) | IF | h and canine | new | ||
HLA-DPα1 항체 (NB-A3) | sc-134358 | mouse IgG2a κ | 1-261 (h) | WB, IP, ELISA | h | 1 | ||
HLA-DQ 항체 (TAL 4.1) | sc-53312 | mouse IgG2b κ | (h) | WB, IF, FCM | h | 1 | ||
HLA-DQ 항체 (B-K27) | sc-65320 | mouse IgG2a | (h) | IP, FCM | h | new | ||
HLA-DQ 항체 (HLADQ1) | sc-73390 | mouse IgG1 | (h) | IF, IHC(P), FCM | h | new | ||
HLA-DQ1/3 항체 (HL-37) | sc-51615 | mouse IgG3 | (h) | WB (non-reducing), IP, FCM | h | new | ||
HLA-DQ3 항체 (2HB6) | sc-53310 | mouse IgG1 κ | (h) | IP, FCM | m | new | ||
HLA-DQ3/DQ4/DR4 항체 (TAL 12.1) | sc-53311 | mouse IgG2b κ | (h) | WB, FCM | h | new | ||
HLA-DQB1 항체 (Genox 3.53) | sc-53313 | mouse IgG1 κ | (h) | WB, IP, IF, FCM | h | new | ||
HLA-DQB1 항체 (IIB3) | sc-59247 | mouse IgG2b κ | IF | h | new | |||
HLA-DR 항체 (520B) | sc-69673 | mouse IgG2b κ | (h) | WB, IP, IF, IHC(P), FCM | h | 2 | ||
HLA-DR 항체 (TAL 1B5) | sc-53319 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | m, r, h | 34 | ||
HLA-DR 항체 (Bra22) | sc-33718 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), FCM | m, r, h | 6 | ||
HLA-DR 항체 (L243) | sc-18875 | mouse IgG2a κ | (h) | IF, IHC(P), FCM | h | 17 | ||
HLA-DR 항체 (2.06) | sc-53517 | mouse IgG1 κ | (h) | WB, IP | m, r, h | 1 | ||
HLA-DR 항체 (ML11C11) | sc-73366 | mouse IgG1 κ | (h) | WB, IP, IF, FCM | h | 1 | ||
HLA-DR 항체 (6A96) | sc-71260 | mouse IgG2b κ | (h) | WB, IP, FCM | m, r, h | new | ||
HLA-DR 항체 (Bra20) | sc-33720 | mouse IgG2b κ | FL (h) | WB, IP, FCM | m, r, h | new | ||
HLA-DR 항체 (Bra30) | sc-33717 | mouse IgG2a κ | (h) | WB, IP, FCM | m, r, h | new | ||
HLA-DR 항체 (LN3) | sc-59252 | mouse IgG2b κ | (h) | WB, IP, FCM | h | new | ||
HLA-DR 항체 (SPM289) | sc-56545 | mouse IgG2b κ | (h) | WB, IP, IF, IHC(P), FCM | m, r, h | new | ||
HLA-DR 항체 (TAL 15.1) | sc-53317 | mouse IgG2a κ | (h) | WB, IP, FCM | h | new | ||
HLA-DR/DP 항체 (HL-40) | sc-51617 | mouse IgG2a | (h) | WB, IP, FCM | h | 5 | ||
HLA-DR/DP 항체 (HL-38) | sc-51616 | mouse IgG2a | (h) | WB (non-reducing), IP, FCM | h | new | ||
HLA-DR/DP 항체 (MEM-136) | sc-51618 | mouse IgG1 | (h) | WB, IP, FCM | h | 3 | ||
HLA-DR/DP/DQ/DX 항체 (CR3/43) | sc-53302 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | h | 13 | ||
HLA-DRα 항체 (G-7) | sc-55593 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 9 | ||
HLA-DRα 항체 (DA6.147) | sc-53499 | mouse IgG1 κ | (h) | WB, IP, IF | m, r, h | 4 | ||
HLA-DRα 항체 (B-10) | sc-55592 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | new | ||
HLA-DRβ 항체 (DA2) | sc-53314 | mouse IgG1 κ | (h) | WB, IP, IF, FCM | h | 3 | ||
HLA-DRβ 항체 (HB10A) | sc-73654 | mouse IgG2a κ | (h) | WB, IP, IF, IHC(P) | h | 1 | ||
HLA-DRβ 항체 (TAL 14.1) | sc-53316 | mouse IgG2a κ | (h) | WB, IP, IF, IHC(P), FCM | h | 2 | ||
HLA-DRβ 항체 (TDR 31.1) | sc-53321 | mouse IgG1 κ | (h) | WB, IP, FCM | h | new | ||
HLA-DRβ 항체 (7.3.19.1) | sc-59261 | mouse IgG2b κ | FL (h) | IF | h | new | ||
HLA-DRβ5 항체 (4D12) | sc-53889 | mouse IgG1 κ | (h) | WB, IP | h | new | ||
HLA-E 항체 (3H2679) | sc-71262 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | h | 3 | ||
HLA-E 항체 (MEM-E/02) | sc-51621 | mouse IgG1 | (h) | WB, IP, IF, IHC(P) | h | 7 | ||
HLA-E 항체 (MEM-E/06) | sc-51622 | mouse IgG1 | (h) | WB, IP, IF, IHC(P), FCM | h | 3 | ||
HLA-E 항체 (MEM-E/08) | sc-51624 | mouse IgG1 | (h) | WB, IP, FCM | h | 2 | ||
HLA-E 항체 (4D12) | sc-517455 | mouse IgG1 κ | (h) | WB, IP, IF, FCM | h | new | ||
HLA-F 항체 (201A2H) | sc-517640 | mouse IgG1 κ | (h) | WB | h | new | ||
HLA-F 항체 (201A2J) | sc-517641 | mouse IgG1 κ | (h) | WB | h | new | ||
HLA-G 항체 (4H84) | sc-21799 | mouse IgG1 κ | 61-83 (h) | WB, IP, IF, IHC(P) | m, r, h | 83 | ||
HLA-G 항체 (MEM-G/9) | sc-51678 | mouse IgG1 | (h) | WB, IP, IF, FCM | h | 7 | ||
HLA-G 항체 (MEM-G/1) | sc-51674 | mouse IgG1 | (h) | WB, IP, IF, IHC(P) | h | 6 | ||
HLA-G 항체 (MEM-G/2) | sc-51676 | mouse IgG1 | (h) | WB, IP, IF, IHC(P) | h | 2 | ||
HLA-G 항체 (6D463) | sc-71263 | mouse IgG1 | (h) | WB, IP, IF, IHC(P) | h | new | ||
HLA-G 항체 (9-1F10) | sc-53825 | mouse IgG1 | (h) | WB, IP, IF, FCM | h | 1 |
HLA CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 제품명 | 카탈로그# | Species | APPLICATIONS | MARKER | 引用 | RATING |
|---|---|---|---|---|---|---|---|
HLA-A CRISPR/Cas9 케이오 플라스미드 (h) | sc-400294 | h | Gene Knockout | GFP | 0 | ||
HLA-A HDR 플라스미드 (h) | sc-400294-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-A 더블 틈내기효소 플라스미드 (h) | sc-400294-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-A 더블 틈내기효소 플라스미드 (h2) | sc-400294-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-B CRISPR/Cas9 케이오 플라스미드 (h) | sc-400627 | h | Gene Knockout | GFP | 0 | ||
HLA-B HDR 플라스미드 (h) | sc-400627-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-B 더블 틈내기효소 플라스미드 (h) | sc-400627-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-B 더블 틈내기효소 플라스미드 (h2) | sc-400627-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-C CRISPR/Cas9 케이오 플라스미드 (h) | sc-401517 | h | Gene Knockout | GFP | 0 | ||
HLA-C HDR 플라스미드 (h) | sc-401517-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-C 더블 틈내기효소 플라스미드 (h) | sc-401517-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-C 더블 틈내기효소 플라스미드 (h2) | sc-401517-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMα 더블 틈내기효소 플라스미드 (h) | sc-404576-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMα 더블 틈내기효소 플라스미드 (h2) | sc-404576-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ CRISPR/Cas9 케이오 플라스미드 (h) | sc-406436 | h | Gene Knockout | GFP | 0 | ||
HLA-DOβ CRISPR/Cas9 케이오 플라스미드 (h) | sc-406402 | h | Gene Knockout | GFP | 0 | ||
HLA-DOβ CRISPR/Cas9 케이오 플라스미드 (m) | sc-420773 | m | Gene Knockout | GFP | 0 | ||
HLA-DRα CRISPR/Cas9 케이오 플라스미드 (h2) | sc-401010-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-DRα HDR 플라스미드 (h2) | sc-401010-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DRα 더블 틈내기효소 플라스미드 (h) | sc-401010-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRα 더블 틈내기효소 플라스미드 (h2) | sc-401010-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-E CRISPR/Cas9 케이오 플라스미드 (h2) | sc-403124-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-E HDR 플라스미드 (h2) | sc-403124-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-E 더블 틈내기효소 플라스미드 (h) | sc-403124-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-E 더블 틈내기효소 플라스미드 (h2) | sc-403124-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-F CRISPR/Cas9 케이오 플라스미드 (h) | sc-410821 | h | Gene Knockout | GFP | 0 | ||
HLA-F 더블 틈내기효소 플라스미드 (h) | sc-410821-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-F 더블 틈내기효소 플라스미드 (h2) | sc-410821-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-G CRISPR/Cas9 케이오 플라스미드 (h2) | sc-401226-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-G HDR 플라스미드 (h2) | sc-401226-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-G 더블 틈내기효소 플라스미드 (h) | sc-401226-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-G 더블 틈내기효소 플라스미드 (h2) | sc-401226-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DP β1 CRISPR/Cas9 케이오 플라스미드 (h) | sc-401413 | h | Gene Knockout | GFP | 0 | ||
HLA-DP β1 HDR 플라스미드 (h) | sc-401413-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DP β1 더블 틈내기효소 플라스미드 (h) | sc-401413-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DP β1 더블 틈내기효소 플라스미드 (h2) | sc-401413-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQA1 CRISPR/Cas9 케이오 플라스미드 (h) | sc-403480 | h | Gene Knockout | GFP | 0 | ||
HLA-DQA1 HDR 플라스미드 (h) | sc-403480-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DQA1 더블 틈내기효소 플라스미드 (h) | sc-403480-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQA1 더블 틈내기효소 플라스미드 (h2) | sc-403480-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQB1 CRISPR/Cas9 케이오 플라스미드 (h2) | sc-403051-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-DQB1 더블 틈내기효소 플라스미드 (h) | sc-403051-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQB1 더블 틈내기효소 플라스미드 (h2) | sc-403051-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ1 CRISPR/Cas9 케이오 플라스미드 (h) | sc-406727 | h | Gene Knockout | GFP | 0 | ||
HLA-DRβ1 더블 틈내기효소 플라스미드 (h) | sc-406727-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ1 더블 틈내기효소 플라스미드 (h2) | sc-406727-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ5 더블 틈내기효소 플라스미드 (h) | sc-402985-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ5 더블 틈내기효소 플라스미드 (h2) | sc-402985-NIC-2 | h | Gene Knockout | Puromycin | 0 |
HLA CRISPR Activation Products
| Empty Table Header | 제품명 | 카탈로그# | Species | APPLICATIONS | MARKER | 引用 | RATING |
|---|---|---|---|---|---|---|---|
HLA-A CRISPR 활성화 플라스미드(h) | sc-400294-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-A 렌티바이러스의 활성화 입자 (h) | sc-400294-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-B CRISPR 활성화 플라스미드(h) | sc-400627-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-C CRISPR 활성화 플라스미드(h) | sc-401517-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRα CRISPR 활성화 플라스미드(h) | sc-401010-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRα CRISPR 활성화 플라스미드(h2) | sc-401010-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E CRISPR 활성화 플라스미드(h) | sc-403124-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E 렌티바이러스의 활성화 입자 (h) | sc-403124-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E CRISPR 활성화 플라스미드(m) | sc-437133-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E CRISPR 활성화 플라스미드(m2) | sc-437133-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E 렌티바이러스의 활성화 입자 (m) | sc-437133-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-F CRISPR 활성화 플라스미드(h) | sc-410821-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-G CRISPR 활성화 플라스미드(h) | sc-401226-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DP β1 CRISPR 활성화 플라스미드(h) | sc-401413-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DP β1 CRISPR 활성화 플라스미드(h2) | sc-401413-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQA1 CRISPR 활성화 플라스미드(h) | sc-403480-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQB1 CRISPR 활성화 플라스미드(h) | sc-403051-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ1 CRISPR 활성화 플라스미드(h) | sc-406727-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ1 CRISPR 활성화 플라스미드(h2) | sc-406727-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ5 CRISPR 활성화 플라스미드(h) | sc-402985-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 |
HLA siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | 제품명 | 카탈로그# | Species | APPLICATIONS | MARKER | 引用 | RATING |
|---|---|---|---|---|---|---|---|
HLA-A siRNA (h) | sc-42908 | h | Gene Silencing | N/A | 0 | ||
HLA-A shRNA 플라스미드 (h) | sc-42908-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-A shRNA (h)렌티바이러스의 입자 | sc-42908-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-B siRNA (h) | sc-42922 | h | Gene Silencing | N/A | 0 | ||
HLA-B shRNA 플라스미드 (h) | sc-42922-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-B shRNA (h)렌티바이러스의 입자 | sc-42922-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-C siRNA (h) | sc-105525 | h | Gene Silencing | N/A | 0 | ||
HLA-C shRNA 플라스미드 (h) | sc-105525-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-C shRNA (h)렌티바이러스의 입자 | sc-105525-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMα siRNA (h) | sc-42909 | h | Gene Silencing | N/A | 0 | ||
HLA-DMα shRNA 플라스미드 (h) | sc-42909-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMα shRNA (h)렌티바이러스의 입자 | sc-42909-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMα siRNA (m) | sc-42910 | m | Gene Silencing | N/A | 0 | ||
HLA-DMα shRNA 플라스미드 (m) | sc-42910-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DMα shRNA (m)렌티바이러스의 입자 | sc-42910-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DM&beta shRNA 플라스미드 (m) | sc-42912-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DM&beta shRNA (m)렌티바이러스의 입자 | sc-42912-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DMβ siRNA (h) | sc-42911 | h | Gene Silencing | N/A | 0 | ||
HLA-DMβ shRNA 플라스미드 (h) | sc-42911-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMβ shRNA (h)렌티바이러스의 입자 | sc-42911-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMβ siRNA (m) | sc-42912 | m | Gene Silencing | N/A | 0 | ||
HLA-DOα siRNA (h) | sc-95165 | h | Gene Silencing | N/A | 0 | ||
HLA-DOα shRNA 플라스미드 (h) | sc-95165-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DOα shRNA (h)렌티바이러스의 입자 | sc-95165-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DOα siRNA (m) | sc-105526 | m | Gene Silencing | N/A | 0 | ||
HLA-DOα shRNA 플라스미드 (m) | sc-105526-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DOα shRNA (m)렌티바이러스의 입자 | sc-105526-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DOβ siRNA (h) | sc-42913 | h | Gene Silencing | N/A | 0 | ||
HLA-DOβ shRNA 플라스미드 (h) | sc-42913-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DOβ shRNA (h)렌티바이러스의 입자 | sc-42913-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DOβ siRNA (m) | sc-42914 | m | Gene Silencing | N/A | 0 | ||
HLA-DOβ shRNA 플라스미드 (m) | sc-42914-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DOβ shRNA (m)렌티바이러스의 입자 | sc-42914-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DRα siRNA (h) | sc-37113 | h | Gene Silencing | N/A | 4 | ||
HLA-DRα shRNA 플라스미드 (h) | sc-37113-SH | h | Gene Silencing | Puromycin | 4 | ||
HLA-DRα shRNA (h)렌티바이러스의 입자 | sc-37113-V | h | Gene Silencing | Puromycin | 4 | ||
HLA-DRα siRNA (m) | sc-37114 | m | Gene Silencing | N/A | 0 | ||
HLA-DRα shRNA 플라스미드 (m) | sc-37114-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DRα shRNA (m)렌티바이러스의 입자 | sc-37114-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-E siRNA (h) | sc-62470 | h | Gene Silencing | N/A | 1 | ||
HLA-E shRNA 플라스미드 (h) | sc-62470-SH | h | Gene Silencing | Puromycin | 1 | ||
HLA-E shRNA (h)렌티바이러스의 입자 | sc-62470-V | h | Gene Silencing | Puromycin | 1 | ||
HLA-E siRNA (m) | sc-62471 | m | Gene Silencing | N/A | 0 | ||
HLA-E shRNA 플라스미드 (m) | sc-62471-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-E shRNA (m)렌티바이러스의 입자 | sc-62471-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-F siRNA (h) | sc-105528 | h | Gene Silencing | N/A | 0 | ||
HLA-F shRNA 플라스미드 (h) | sc-105528-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-F shRNA (h)렌티바이러스의 입자 | sc-105528-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-G siRNA (h) | sc-42920 | h | Gene Silencing | N/A | 2 | ||
HLA-G shRNA 플라스미드 (h) | sc-42920-SH | h | Gene Silencing | Puromycin | 2 | ||
HLA-G shRNA (h)렌티바이러스의 입자 | sc-42920-V | h | Gene Silencing | Puromycin | 2 | ||
HLA-G siRNA (m) | sc-42921 | m | Gene Silencing | N/A | 0 | ||
HLA-G shRNA 플라스미드 (m) | sc-42921-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-G shRNA (m)렌티바이러스의 입자 | sc-42921-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DP β1 siRNA (h) | sc-43929 | h | Gene Silencing | N/A | 0 | ||
HLA-DP β1 siRNA (h) | sc-42915 | h | Gene Silencing | N/A | 0 | ||
HLA-DP β1 shRNA 플라스미드 (h) | sc-42915-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DP β1 shRNA 플라스미드 (h) | sc-43929-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DP β1 shRNA (h)렌티바이러스의 입자 | sc-42915-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DP β1 shRNA (h)렌티바이러스의 입자 | sc-43929-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DPα1 siRNA (h) | sc-95353 | h | Gene Silencing | N/A | 0 | ||
HLA-DPα1 shRNA 플라스미드 (h) | sc-95353-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DPα1 shRNA (h)렌티바이러스의 입자 | sc-95353-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQA1 siRNA (h) | sc-105527 | h | Gene Silencing | N/A | 0 | ||
HLA-DQA1 shRNA 플라스미드 (h) | sc-105527-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQA1 shRNA (h)렌티바이러스의 입자 | sc-105527-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQB1 siRNA (h) | sc-42918 | h | Gene Silencing | N/A | 0 | ||
HLA-DQB1 shRNA 플라스미드 (h) | sc-42918-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQB1 shRNA (h)렌티바이러스의 입자 | sc-42918-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-HB1 siRNA (h) | sc-91802 | h | Gene Silencing | N/A | 0 | ||
HLA-HB1 shRNA 플라스미드 (h) | sc-91802-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-HB1 shRNA (h)렌티바이러스의 입자 | sc-91802-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQA2 siRNA (h) | sc-42917 | h | Gene Silencing | N/A | 0 | ||
HLA-DQA2 shRNA 플라스미드 (h) | sc-42917-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQA2 shRNA (h)렌티바이러스의 입자 | sc-42917-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DRβ5 siRNA (h) | sc-72095 | h | Gene Silencing | N/A | 0 | ||
HLA-DRβ5 shRNA 플라스미드 (h) | sc-72095-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DRβ5 shRNA (h)렌티바이러스의 입자 | sc-72095-V | h | Gene Silencing | Puromycin | 0 |
HLA Transfected Lysates
| Empty Table Header | 제품명 | 카탈로그# | Species | CONTROL ANTIBODY | 引用 | RATING |
|---|---|---|---|---|---|---|
HLA-G (h2): 293T Lysate | sc-159524 | h2 | 0 |